VEGF-C has been shown to be sufficient to induce tumor lymphangiogenesis by melanoma [16, 17], breast cancer [4, 12, 18], fibrosarcoma [17], and gastric carcinoma cells [19]. The gene discussed is VEGFC; the disease is gastric carcinoma.